ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2025
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • 2020-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstracts tagged "Health Care"

  • Abstract Number: 0880 • ACR Convergence 2025

    Detecting Interstitial Lung Disease and Identifying Extensive Disease on Chest Computed Tomography in Patients with Systemic Sclerosis: Cut-Offs for Lung Texture Analysis and its Prognostic Implications

    Nicholas landini1, lisa Jungblut2, cecilia strappa3, Christian Blüthgen2, Rucsandra Dobrota4, Muriel Elhai5, Carina Mihai6, Sinziana Muraru-Carbune2, Martina Orlandi7, mariaelena Occhipinti8, Khadija El-Aoufy9, Gemma Lepri10, valeria panebianco11, anna rita larici3, Anna-Maria Hoffmann-Vold12, Cosimo Nardi13, Serena Guiducci14, Silvia Bellando-Randone15, Marco Matucci-Cerinic16, Thomas Frauenfelder2, Oliver Distler17 and Cosimo Bruni18, 1Department of Radiological Sciences, Oncology and Pathology, "Sapienza" University, Policlinico Umberto I, Rome, Italy. Department of Rheumatology, University Hospital Zurich, University of Zurich, Zurich, Switzerland, Rueil Malmaison, France, 2Institute for Diagnostic and Interventional Radiology, University Hospital Zurich, University Zurich, Zurich, Switzerland, zurich, Switzerland, 3Advanced Radiology Center, Department of Diagnostic Imaging and Oncological Radiotherapy, Fondazione Policlinico Universitario "A. Gemelli" IRCCS, Rome, Italy, rome, Italy, 4Center of Experimental Rheumatology, Department of Rheumatology, University Hospital Zurich, University of Zurich, the LOOP Zurich, Zurich, Switzerland, 5Institute for Diagnostic and Interventional Radiology, University Hospital Zurich, University Zurich, Zurich, Switzerland, Schlieren, Switzerland, 6University Hospital Zurich, University of Zurich, Zurich, Switzerland, 7Rheumatology Unit, Department of Medical and Surgical Sciences for Children and Adults, University Hospital of Modena and Reggio Emilia School of Medicine, Italy., modena, Italy, 8Division of Radiology, Fondazione Toscana Gabriele Monasterio, Pisa, Italy., pisa, Italy, 9Department of Health Science, University of Florence, Florence, Italy., firenze, Italy, 10Department of Experimental and Clinical Medicine, University of Florence, Division of Rheumatology Scleroderma Unit, AOU Careggi Hospital, Florence, Italy., Florence, Italy, 11Department of Radiological Sciences, Oncology and Pathology, "Sapienza" University, Policlinico Umberto I, Rome, Italy., Rome, Italy, 12Oslo University Hospital, Oslo, Norway, 13Department of Experimental and Clinical Biomedical Sciences, Radiodiagnostic Unit n. 2, University of Florence - Azienda Ospedaliero-Universitaria Careggi, Florence, Italy, Florence, Italy, 14Department of Experimental and Clinical Medicine, Scleroderma Unit, Division of Rheumatology, University of Florence, Azienda Ospedaliera Universitaria Careggi, Florence, Italy, Pistoia, Italy, 15University of Florence, Florence, Florence, Italy, 16University San Raffaele Milano, Milano, Milan, Italy, 17Department of Rheumatology, University Hospital Zurich, University of Zurich, Switzerland, Zurich, Switzerland, 18University of Zurich, Zurich, Switzerland

    Background/Purpose: Interstitial lung disease (ILD) is a leading cause of death in patients with systemic sclerosis (SSc), especially in case of extensive disease detected on…
  • Abstract Number: 1928 • ACR Convergence 2025

    Oral Health in Patients with Rheumatic Diseases: A Pilot Quality Improvement Program

    Margarita Isabel Alarcon-Jarquin1, Fernanda M. Garcia-Garcia2, Vanessa L. Lopez-Flores1, Aleydis Gonzalez-Melendez3, Gabriel Figueroa-Parra3, Dionicio A. Galarza-Delgado2 and Janett C. Riega-Torres4, 1Rheumatology Service, University Hospital “Dr. José Eleuterio González”, Universidad Autónoma de Nuevo León, Monterrey, Nuevo Leon, Mexico, 2Rheumatology Service, Hospital Universitario Dr. José Eleuterio González, Universidad Autónoma de Nuevo León, Monterrey, Mexico, 3Rheumatology Service, Hospital Universitario “Dr. Jose Eleuterio Gonzalez”, Universidad Autonoma de Nuevo Leon, Monterrey, Mexico, 4Rheumatology Service, Hospital Universitario “Dr. Jose Eleuterio Gonzalez”, Universidad Autonoma de Nuevo Leon, Monterrey, Nuevo Leon, Mexico

    Background/Purpose: Patients with rheumatic diseases commonly experience oral health issues such as dental caries, xerostomia, and periodontal disease. These complications are linked to both the…
  • Abstract Number: 0829 • ACR Convergence 2025

    Multi-Center Use of an Online Case-Based Simulation to Evaluate Medical Trainee Use of Diagnostic Imaging and Lab Tests to Correctly Diagnose MSK Complaints

    James McCarthey1, Kyla Driest2, erin frank1, Allayne Stephans1, Stacey Tarvin3 and Angela Robinson4, 1Rainbow Babies and Children's Hospital, Cleveland, OH, 2Nationwide Children's Hospital, Columbus, OH, 3Riley Hospital for Children at Indiana University, Indianapolis, IN, 4Cleveland Clinic Foundation, Cleveland, OH

    Background/Purpose: Our goal is to teach medical trainees high value care concepts and musculoskeletal (MSK) disease states and then implement online case-based simulations to evaluate…
  • Abstract Number: 1910 • ACR Convergence 2025

    Clinical profile and healthcare resource utilization of patients diagnosed with giant cell arteritis or polymyalgia rheumatica in the US: a real-world cohort study using a large database of administrative health claims

    Julie Mouchet1, Tim Nguyen2, Valeria Jordan M.3, G S Ramakrishna4, Linda Grinnell-Merrick2, Andrew Heaney5, Anushka Mitra Das5, Pooja Shah6 and Evi Zhuleku7, 1Novartis Pharma AG, Basel, Switzerland, 2Novartis Pharmaceuticals Corporation, East Hanover, NJ, 3Novartis Pharmaceuticals Corporation, Tenafly, NJ, 4Novartis Healthcare Private Limited, Hyderabad, India, 5Novartis Ireland Ltd, Dublin, Ireland, 6Cytel Inc, Cambridge, ON, Canada, 7Cytel Inc, Berlin, Germany

    Background/Purpose: Polymyalgia rheumatica (PMR) and giant cell arteritis (GCA) are systemic inflammatory conditions which predominantly affect individuals over the age of 50 years. The conditions…
  • Abstract Number: 0761 • ACR Convergence 2025

    Fast-Track Clinics Improve Visual Outcomes in Giant Cell Arteritis: A Meta-Analysis

    Tiago Beirão1, Catarina Rua1, Catarina Silva1, Mariana Patela1, Romana Vieira1, Joana Abelha-aleixo1, Patrícia Pinto1, Flávio Costa1, Ana Sofia Pinto1, Diogo Fonseca1, Tiago Meirinhos1, Ajexandro Souto2 and Taciana Videira1, 1Unidade Local de Saude Gaia e Espinho, Porto, Portugal, 2Hospital Clínico Universitario de Santiago, Santiago de Compostela, Spain

    Background/Purpose: Giant Cell Arteritis (GCA) is a chronic, inflammatory condition, primary affecting the medium and larger arteries, usually in patients older than 50 years. It…
  • Abstract Number: 1727 • ACR Convergence 2025

    Distribution of Fracture Risk Status and Osteoporosis Treatment Use Among Postmenopausal Women with Osteoporosis in the United States

    Hsu-Chih Chien, Min Kim, Michele McDermott, Mary Oates, Xiaodong Li and Lara Yoon, Amgen Inc, Thousand Oaks, CA

    Background/Purpose: Current guidelines recommend treating women with postmenopausal osteoporosis (PMO) based on fracture risk. Anabolic therapy (AT), the RANKL inhibitor denosumab (Dmab), and intravenous zoledronic…
  • Abstract Number: 0546 • ACR Convergence 2025

    Multimorbidity clusters in psoriatic arthritis, psoriasis, and axial spondyloarthritis and their association with healthcare utilization: A population-based study

    Paras Karmacharya1, Dilli Poudel2, Daniel Shin3, Robert Fitzsimmons3, Leslie Crofford4 and Alexis Ogdie5, 1Vanderbilt University, Nashville, TN, Hermitage, TN, 2Vanderbilt University Medical Center, Nashville, TN, 3University of Pennsylvania, Philadelphia, 4Vanderbilt University Medical Center, Melbourne, AR, 5University of Pennsylvania, Philadelphia, PA

    Background/Purpose: Multimorbidity (≥ 2 chronic conditions) is common in inflammatory diseases such as psoriatic arthritis (PsA), psoriasis (PsO), and axial spondyloarthritis (AxSpA), increasing patient burden…
  • Abstract Number: 1706 • ACR Convergence 2025

    Overcoming Barriers to ANA Testing in Pediatric Populations in Africa

    Ekemini Ogbu1, Angela Migowa2, Rashmi Sahay1, Dhriti Sharma1, Patricia Vega-Fernandez1, Michael Henrickson1, Evans Omalla3, Ayodele Faleye4, Wafa Hamdi5 and Hermine Brunner1, 1Cincinnati Children's Hospital Medical Center, Cincinnati, OH, 2Aga Khan University Medical College East Africa, Nairobi, Kenya, 3Pediatric Society of the African League Against Rheumatism, Nairobi, Kenya, 4Lagos state university teaching hospital Ikeja, Lagos, Lagos, Nigeria, 5Kassab Institute, Faculty of Medicine of Tunis UR17SP04, Tunis El Manar Univeristy, MANOUBA, Tunisia

    Background/Purpose: Timely diagnosis of children, adolescents and young adults with rheumatologic disorders remains a global challenge especially in lower resource countries and areas (LRCs). There…
  • Abstract Number: 0525 • ACR Convergence 2025

    Cost-of-Illness Among Newly Diagnosed Patients with Psoriatic Arthritis in Sweden

    Sofia Wittgren1, Sofia Exarchou2, Daniela Di Giuseppe3, Ulf Lindström4, Tor Olofsson1, Lennart T. H. Jacobsson4, Johan Askling3 and Johan Karlsson Wallman1, 1Lund University, Skane University Hospital, Department of Clinical Sciences Lund, Rheumatology, Lund, Skane Lan, Sweden, 2Lund University, Åkarp, Skane Lan, Sweden, 3Karolinska Institutet, Department of Medicine Solna, Clinical Epidemiology Division, Stockholm, Stockholms Lan, Sweden, 4Gothenburg University, Sahlgrenska Academy, Department of Rheumatology and Inflammation Research, Gothenburg, Vastra Gotaland, Sweden

    Background/Purpose: Up-to-date information on the cost-of-illness of psoriatic arthritis (PsA) is important for healthcare/social insurance system budgeting and to highlight unmet needs in PsA care.…
  • Abstract Number: 1705 • ACR Convergence 2025

    Associations Between Social Risk Factors and Acute Care Use Among Patients with Rheumatic Conditions

    Haelynn Gim1, Leah Santacroce2, Rebecca Summit3, Karli Retzel4, Virginia Bills4, Nancy Shadick3, Sara Schoenfeld5 and Candace Feldman2, 1Harvard Medical School, Brookline, MA, 2Brigham and Women's Hospital, Boston, MA, 3Brigham & Women's Hospital, Boston, MA, 4Brigham & Women's Hospital, Boston, 5Massachusetts General Hospital, Boston, MA

    Background/Purpose: Adverse social determinants of health, or social risk factors (e.g., housing instability, food insecurity), contribute to disparities in rheumatic disease care and outcomes. Understanding…
  • Abstract Number: 0368 • ACR Convergence 2025

    Factors Associated with Patient Acceptability of Rheumatology Care Delivered by Telemedicine

    Hareem Farooq1, Lesley Jackson1, Rahima Begum2, Gary Cutter2, Kenneth Saag3, Jinoos Yazdany4 and Maria I. ("Maio") Danila5, 1University of Alabama at Birmingham, Birmingham, AL, 2University of Alabama at Birmingham, Birmingham, 3The University of Alabama at Birmingham, Birmingham, AL, 4UCSF, San Francisco, CA, 5University of Alabama at Birmingham (UAB), Birmingham VA Medical Center, Birmingham, AL

    Background/Purpose: Home-based telemedicine is an efficient healthcare delivery approach. A recent randomized clinical trial (RCT) found that in-person visits may be preferred among rheumatology patients.…
  • Abstract Number: 0985 • ACR Convergence 2024

    Specific Causes for Hospitalization in Persons with Inflammatory Arthritis Conditions and Gout: A Systematic Review

    Kara Irwin, Ran Huo, Alandra Ward, Ciana Sudheer, Allan Li, Claire Barber and Cheryl Barnabe, University of Calgary, Calgary, AB, Canada

    Background/Purpose: Knowing which diagnoses result in a high frequency of hospitalization in persons with inflammatory arthritis (IA) and gout can inform health system planning and…
  • Abstract Number: 1907 • ACR Convergence 2024

    Community-Engaged Curriculum Development Using Racial Justice and Biomedical Lenses to Address COVID-19 Vaccine Hesitancy in Black Individuals with Rheumatologic Conditions

    Eseosa Osaghae1, Greta Sirek2, Tonya Roberson3, Mia Chandler4, Ariel Childs5, Monica Crespo-Bosque6, Gina Curry7, Amar Dhand8, Mary Dollear9, Alice Eggleston10, Nnenna Ezeh2, Dieufort Fleurissaint11, Denice Garrett12, Gail Granville13, Muriel Jean-Jacques1, Elena Losina2, Holly Milaeger1, Lutfiyya Muhammad14, Mary Ann Nelson15, Chisa Nosamiefan16, Bisola Ojikutu17, Neil Pillai1, Marie Jacques Toussaint18, Mary Beth Son19, Ana Valle2, Jessica Williams20, Michael York21, Karen Mancera-Cuevas22, Candace Feldman2 and rosalind Ramsey-Goldman1, 1Northwestern University, Chicago, IL, 2Brigham and Women's Hospital, Boston, MA, 3Governors State University College of Health and Human Services, University Park, IL, 4Boston Children’s Hospital, Boston, MA, 5Vital CxNs, Boston, MA, 6Boston Medical Center, Boston, MA, 7University of Chicago Pritzker School of Medicine, Chicago, IL, 8Brigham and Women’s Hospital, Boston, MA, 9Lupus Society of Illinois, Chicago, IL, 10Alliance Chicago, Chicago, IL, 11True Alliance Center, Inc, Boston, MA, 12Action for Bridgeport Community Development, Inc., Bridgeport, CT, 13Women of Courage, Inc, Boston, MA, 14Northwestern Feinberg School of Medicine, Chicago, IL, 15Mission Hill Health Movement Inc, Roxbury, MA, 16The Labalaba Foundation for Lupus Awareness and Advocacy, South Weymouth, MA, 17Harvard Medical School, Brigham and Women’s Hospital, Boston Public Health Commission,, Boston, MA, 18True Alliance Center, Inc., Boston, MA, 19Boston Children's Hospital, Brookline, MA, 20Emory School of Medicine, Atlanta, GA, 21Boston University, Boston, MA, 22National Health Council, Washington, DC

    Background/Purpose: Despite the efficacy of COVID-19 vaccines and the benefits for individuals with rheumatic conditions, racial inequities in uptake persist. We initiated a trial that…
  • Abstract Number: 1020 • ACR Convergence 2024

    Health Inequalities Exist Between the United States and Europe for Patients with Axial Spondyloarthritis

    Elena Nikiphorou1, Alexis Ogdie2, Dan Twigg3, Emily Quiñones4, You-Li Ling5, Karim Masri6, Joseph C. Cappelleri7, Lidia Sanchez-Riera8, Megan Hughes9 and NICOLA MASSEY9, 1King's College London, London, United Kingdom, 2Department of Medicine, Perelman School of Medicine at the University of Pennsylvania, Philadelphia, PA, 3Adelphi Real World, Manchester, United Kingdom, 4Adelphi Real World, Macclesfield, United Kingdom, 5Pfizer Inc, New York, NY, 6Pfizer Inc, Collegeville, PA, 7Pfizer, Groton, 8Pfizer, Madrid, 9Adelphi Real World, Bollington, United Kingdom

    Background/Purpose: Structural differences exist between the healthcare systems in the United States (US) and Europe. In real-world clinical settings, we investigated whether these differences create…
  • Abstract Number: 1916 • ACR Convergence 2024

    Healthcare Disparities and Clinical Outcomes in Cardiac Sarcoidosis. a Retrospective Cohort Study

    Yurilu Gonzalez Moret1, Diego Lema2, kevin Lo3 and Fabian Rodriguez Quinonez4, 1Jefferson Einstein Hospital, Philadelphia, PA, 2Universidad Central de Venezuela, University of Wisconsin, Philadelphia, PA, 3Brigham and Women's Hospital, Boston, MA, 4Einstein Medical Center Philadelphia, Philadelphia, PA

    Background/Purpose: Sarcoidosis is a condition affecting multiple organ systems, characterized by the presence of non-caseating granulomas. Cardiac sarcoidosis (CS) is a challenging diagnosis, with a…
  • « Previous Page
  • 1
  • 2
  • 3
  • 4
  • 5
  • …
  • 16
  • Next Page »
Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

Embargo Policy

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM CT on October 25. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology